524516
BACPHAR
Start SIP
Invest Now
Start SIP in BACPHAR
Performance
- Low
- ₹38
- High
- ₹40
- 52 Week Low
- ₹27
- 52 Week High
- ₹48
- Open Price₹38
- Previous Close₹38
- Volume110
- 50 DMA₹39.60
- 100 DMA₹39.35
- 200 DMA₹38.23
Investment Returns
- Over 1 Month -1.86%
- Over 3 Month + 26.64%
- Over 6 Month + 5.11%
- Over 1 Year -12.61%
Smart Investing Starts Here Start SIP with Bacil Pharma for Steady Growth!
Bacil Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 89.1
- PEG Ratio
- 1.4
- Market Cap Cr
- 57
- P/B Ratio
- 2.1
- Average True Range
- 3.11
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.44
- RSI
- 43.34
- MFI
- 31.27
Bacil Pharma Financials
Bacil Pharma Technicals
EMA & SMA
Current Price
₹39.50
+
1.4
(3.67%)
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹40.20
- 50 Day
- ₹39.60
- 100 Day
- ₹39.35
- 200 Day
- ₹38.23
Resistance and Support
38.37
- R3 45.73
- R2 43.37
- R1 40.73
- S1 35.73
- S2 33.37
- S3 30.73
Bacil Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-09-05 | Others | Inter-alia, to consider 1. Fix Date, Place, Timing and Notice for 38th AGM of the Company. 2. Director Report of the Company for the Financial Year 2024-2025. 3. Other business matters. |
| 2025-08-25 | Others | Inter-alia, to consider 1. Discussion on Appointment of M/s Sarang Shivajirao Chavan & Associate as a Statutory Auditor of the Company. 2. Appointment of New Director. 3. Other business matters. |
| 2025-08-12 | Quarterly Results | |
| 2025-07-16 | Others | Inter-alia, to consider 1. Appointment of a new Executive Director and Chief Financial Officer of the Company. 2. Resignation of the present Chief Financial Officer. 3. Other business matters. |
Bacil Pharma F&O
About Bacil Pharma
- NSE Symbol
- BACPHAR
- BSE Symbol
- 524516
- ISIN
- INE711D01018
Similar Stocks to Bacil Pharma
Bacil Pharma FAQs
Bacil Pharma share price is ₹39 As on 06 February, 2026 | 09:46
The Market Cap of Bacil Pharma is ₹56.7 Cr As on 06 February, 2026 | 09:46
The P/E ratio of Bacil Pharma is 89.1 As on 06 February, 2026 | 09:46
The PB ratio of Bacil Pharma is 2.1 As on 06 February, 2026 | 09:46
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.